FDA IRB warning letter: Jamaica Hospital Institutional Review Board

FDA issued a warning letter to an IRB this week. Jamaica Hospital Institutional Review Board was warned for:

  • Failing to prepare and maintain adequate documentation of IRB activities, specifically:
    • Five instances where IRB meeting minutes did not document specific vote counts on FDA regulated studies
  • Failure to maintain up to date membership lists over two years